278 related articles for article (PubMed ID: 30909205)
1. Cancer-testis antigens: An update on their roles in cancer immunotherapy.
Taherian-Esfahani Z; Dashti S
Hum Antibodies; 2019; 27(3):171-183. PubMed ID: 30909205
[TBL] [Abstract][Full Text] [Related]
2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
3. A novel era of cancer/testis antigen in cancer immunotherapy.
Meng X; Sun X; Liu Z; He Y
Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
[TBL] [Abstract][Full Text] [Related]
4. Expression of cancer-testis antigens in stem cells: is it a potential drawback or an advantage in cancer immunotherapy.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(7):3079-81. PubMed ID: 25854409
[TBL] [Abstract][Full Text] [Related]
5. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
Gordeeva O
Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
[TBL] [Abstract][Full Text] [Related]
6. The potential immune-eliciting cancer testis antigens in colorectal cancer.
Chi Soh JE; Abu N; Jamal R
Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
8. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cancer-Testis Antigens in Pediatric Cancers.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
[TBL] [Abstract][Full Text] [Related]
10. Roles of cancer/testis antigens (CTAs) in breast cancer.
Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
[TBL] [Abstract][Full Text] [Related]
11. Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S
Immunotherapy; 2018 Apr; 10(5):411-421. PubMed ID: 29473472
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.
Zhang Y; Zhang Y; Zhang L
J Cancer Res Clin Oncol; 2019 Feb; 145(2):281-291. PubMed ID: 30656409
[TBL] [Abstract][Full Text] [Related]
13. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
14. Cellular Mucins: Targets for Immunotherapy.
Apostolopoulos V; McKenzie IFC
Crit Rev Immunol; 2017; 37(2-6):421-437. PubMed ID: 29773028
[TBL] [Abstract][Full Text] [Related]
15. Cancer testis antigens as immunogenic and oncogenic targets in breast cancer.
Mahmoud AM
Immunotherapy; 2018 Jul; 10(9):769-778. PubMed ID: 29926750
[TBL] [Abstract][Full Text] [Related]
16. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials.
Malla R; Srilatha M; Muppala V; Farran B; Chauhan VS; Nagaraju GP
J Control Release; 2024 Jun; 370():707-720. PubMed ID: 38744346
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Sep; 9(12):1019-1034. PubMed ID: 28971747
[TBL] [Abstract][Full Text] [Related]
18. Cancer/testis antigens: from serology to mRNA cancer vaccine.
Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses against cancer-testis antigens in human malignancies.
Astaneh M; Dashti S; Esfahani ZT
Hum Antibodies; 2019; 27(4):237-240. PubMed ID: 31006681
[TBL] [Abstract][Full Text] [Related]
20. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Scanlan MJ; Gure AO; Jungbluth AA; Old LJ; Chen YT
Immunol Rev; 2002 Oct; 188():22-32. PubMed ID: 12445278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]